Kerala Ayurveda Share Price
181.50+8.60 (+4.97%)
-61.36% past 1 Year
KAL was founded on the banks of river Periyar at Aluva, Kochi, Kerala, India in 1945 by Late Vaidyan K G K Panicker, the renowned Ayurvedacharya. He was a doyen
Corporate filings & documents
Announcements
Kerala Ayurveda Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/09/2026 inter alia to consider and approve Inter alia to Consider and evaluate the proposal of preferential issue of equity shares in one or more tranches
2 days agoKerala Ayurveda Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/09/2026 inter alia to consider and approve Inter alia to Consider and evaluate the proposal of preferential issue of equity shares in one or more tranches
2 days agoAnnouncement under Regulation 30 (LODR)-Newspaper Publication
3 weeks agoAnnouncement under Regulation 30 (LODR)-Newspaper Publication
3 weeks agoAnnouncement under Regulation 30 (LODR)- Scheme of Arrangement
3 weeks agoAnnouncement under Regulation 30 (LODR)- Scheme of Arrangement
3 weeks agoAnnouncement under Regulation 30(LODR)- Press Release
3 weeks agoAnnouncement under Regulation 30(LODR)- Press Release
3 weeks agoAnnouncement under Regulation 30 (LODR) - Allotment of ESOP
3 weeks agoAnnouncement under Regulation 30 (LODR) - Allotment of ESOP
3 weeks agoResults - Financial Results for the Quarter ended 30th June 2026
3 weeks agoResults - Financial Results for the Quarter ended 30th June 2026
3 weeks agoOutcome of Board 12th August 2026
3 weeks agoOutcome of Board 12th August 2026
3 weeks agoKerala Ayurveda Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 inter alia to consider and approve the unaudited financial results (standalone and consolidated) of the Company for the quarter ended June 30 2026.
4 weeks agoKerala Ayurveda Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 inter alia to consider and approve the unaudited financial results (standalone and consolidated) of the Company for the quarter ended June 30 2026.
4 weeks agoCertificate under Reg.74(5) of SEBI (DP) Regulations 2018
2 months agoCertificate under Reg.74(5) of SEBI (DP) Regulations 2018
2 months agoclosure of trading window
2 months agoclosure of trading window
2 months agoNews paper publication
2 months agoNews paper publication
2 months agoRevised Corporate announcement Pursuant to the query raised from BSE
2 months agoRevised Corporate announcement Pursuant to the query raised from BSE
2 months agoResignation of Independent Director
2 months agoResignation of Independent Director
2 months agoIntimation under regulation 30(5)
2 months agoIntimation under regulation 30(5)
2 months agoAppointment of Company secretary and Compliance officer
2 months agoAppointment of Company secretary and Compliance officer
2 months agoAppointment of New Company Secretary
2 months agoAppointment of New Company Secretary
2 months agoASCR 2026
3 months agoASCR 2026
3 months agoNewspaper publication - Financial Results
3 months agoNewspaper publication - Financial Results
3 months agoPress Release
3 months agoAppointment of Internal Auditor and Cost Auditor
3 months agoAppointment of Internal Auditor and Cost Auditor
3 months agoFinancial Results for the Year Ended 31st March 2026
3 months agoOutcome of Board meeting held on 25th May 2026
3 months agoOutcome of Board meeting held on 25th May 2026
3 months agoKerala Ayurveda Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/05/2026 inter alia to consider and approve Board meeting on 25th May 2026
3 months ago<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Kerala Ayurveda Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L24233KL1992PLC006592</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>70.47</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>NIL</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: The Company is in the process of appointing a Company Secretary <br/> Designation: Kunjupanicker Anil Kumar Wholetime Director <br/> EmailId: [email protected]</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: George K T <br/> Designation: Chief Financial Officer <br/> EmailId: [email protected]</div> </div> <div> <br/> Date: 27/04/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>
4 months agoAnnouncement Under Regulation 30 (LODR)
4 months agoClarification on Price Movement
4 months agoClarification on Price Movement
4 months agoThe Exchange has sought clarification from Kerala Ayurveda Ltd on April 8 2026 with reference to significant movement in price in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.<BR><BR>The reply is awaited.
4 months agoThe Exchange has sought clarification from Kerala Ayurveda Ltd on April 8 2026 with reference to significant movement in price in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.<BR><BR>The reply is awaited.
4 months agoCertificate under Reg.75(5) of SEBI(D)Regulations 2018
5 months agoAnnual reports
Concalls & investor presentations
May 2022
ConcallPresentation
Corporate Actions
Date
Type
Details
No data available.
Company details
Registered office
X V /551 Athani Nedumbassery Ernakulam Kerala PIN: 683585 Tel No: 0484 2476301 Fax No: 0484 2474376 Email: [email protected] Internet: www.keralaayurveda.biz
Registrars
II Floor , Kences Towers,No 1 Ramakrishna Street,North Usman Road, T Nagar,Chennai II Floor , Kences Towers No 1 Ramakrishna Street North Usman Road, T Nagar PIN: Tel No: 044-28140801 Fax No: 044-28142479 Email: [email protected] Internet: [email protected]
Management
Ramesh Vangal, Chairman
Kunjupanicker Anilkumar, Whole Time Director
Shilpa Kiran Gududur, Non Executive Independent Director
Rajesh Sharma, Non Executive Independent Director
Binu Thomas, Company Secretary and Compliance Officer
Kshiti Ranjan Das, Non Executive Independent Director
Kodikannath Jayarajan, Non Executive Director
Utkarsh Singh, Non Executive Director
Details
BSE 530163
NSE NULL
ISIN INE817B01025